# Characterization of protein lactylation in healthy and ischemic mouse hearts

## TL;DR

This study maps protein lactylation in healthy and ischemic mouse hearts, revealing its role in heart disease and metabolic shifts.

## Contribution

The first comprehensive lactylation atlas in mouse hearts, linking lactylation to myocardial infarction and metabolic changes.

## Key findings

- MI shifts heart metabolism toward glycolysis and increases protein lactylation levels.
- Lactylome profiling identified 1,674 lactylation sites across 477 cardiac proteins.
- Altered lactylation in MI affects metabolic enzymes, cytoskeletal, and RNA binding proteins.

## Abstract

Recent findings highlight the growing importance of protein lactylation, a modification driven by lactate, in healthy and diseased states. However, its significance in myocardial infarction (MI) remains unclear. Here, we characterized lactylation in healthy and ischemic hearts, revealing its profound implications.

Global proteomics and lactylome profiling were conducted on the hearts of healthy mice and mice with induced MI. Protein expression analysis, enrichment analysis, cellular compartment analysis, and protein-protein interaction network construction were conducted to identify potential molecular features. The changes in total protein lactylation levels and the lactylation levels of identified representative proteins in healthy and ischemic hearts were validated.

Proteomic analysis revealed that MI led to a metabolic shift from oxidative phosphorylation and fatty acid β-oxidation toward hypoxia-induced glycolysis. Western blotting and immunofluorescence analyses conclusively demonstrated the presence of protein lactylation in healthy hearts, with significantly elevated lactylation levels following MI. Lactylome profiling identified 1,674 lactylation sites across 477 cardiac proteins under physiological conditions, with 44.03% (210/477) being singly-lactylated proteins. Myosin-6 and titin were identified as the proteins having the most lactylation sites in the heart. Comparative analysis revealed 61 upregulated lactylation sites across 53 proteins and 30 downregulated sites across 27 proteins in infarcted hearts relative to healthy controls. Functional enrichment analyses suggested that proteins with altered lactylation modification post-MI mainly included metabolic enzymes, cytoskeletal proteins, and RNA binding proteins. We created lactylation modification maps for these three types of proteins in ischemic hearts.

We present the first comprehensive lactylation atlas in healthy and ischemic mouse hearts, offering new avenues to explore MI and cardiovascular diseases.